Division of General Academic Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI.
J Pediatr. 2014 Mar;164(3):536-41. doi: 10.1016/j.jpeds.2013.11.021. Epub 2013 Dec 22.
To determine prognostic factors that independently predict response to antimicrobial therapy in children with acute sinusitis.
A total of 206 children meeting a priori clinical criteria for acute sinusitis who were prescribed antimicrobial therapy by their primary care provider were included. The severity of symptoms in the 8-12 days after treatment was initiated was followed with the use of a validated scale. We examined the univariate and multivariate association between factors present at the time of diagnosis (symptoms, signs, nasopharyngeal culture result, radiograph results) and time to resolution of symptoms. This study was conducted 8-10 years after the 7-valent pneumococcal conjugate vaccination was introduced but before introduction of the 13-valent pneumococcal conjugate vaccination.
Children with proven nasopharyngeal colonization with Streptococcus pneumoniae improved more rapidly (6.5 vs 8.5 median days to symptom resolution) than those who were not colonized with S pneumoniae. Age and radiograph findings did not predict time to symptom resolution.
In children with acute sinusitis, proven nasopharyngeal colonization with S pneumoniae at presentation independently predicted time to symptom resolution. Future randomized, placebo-controlled trials could investigate the usefulness of testing for the presence of nasopharyngeal pathogens as a predictor of response to treatment.
确定能够独立预测儿童急性鼻窦炎对抗菌治疗反应的预后因素。
共纳入 206 名符合急性鼻窦炎预先设定临床标准并由初级保健提供者开具抗菌治疗处方的儿童。使用验证后的量表在治疗开始后 8-12 天内随访症状的严重程度。我们检查了诊断时存在的(症状、体征、鼻咽培养结果、影像学结果)因素与症状缓解时间之间的单变量和多变量关联。本研究在 7 价肺炎球菌结合疫苗引入 8-10 年后进行,但在 13 价肺炎球菌结合疫苗引入之前进行。
与未被肺炎链球菌定植的儿童相比,鼻咽部有肺炎链球菌定植的儿童症状缓解更快(中位时间分别为 6.5 天和 8.5 天)。年龄和影像学结果不能预测症状缓解时间。
在患有急性鼻窦炎的儿童中,就诊时鼻咽部有肺炎链球菌定植可独立预测症状缓解时间。未来的随机、安慰剂对照试验可以研究检测鼻咽病原体存在作为治疗反应预测指标的有用性。